The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery ...